These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22022175)

  • 21. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.
    Pituch H; van den Braak N; van Leeuwen W; van Belkum A; Martirosian G; Obuch-Woszczatyński P; Łuczak M; Meisel-Mikołajczyk F
    Clin Microbiol Infect; 2001 Aug; 7(8):442-6. PubMed ID: 11591209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial-acquired and community-onset Clostridium difficile infection at an academic hospital in Italy: Epidemiology, recurrences and toxin genes distribution.
    Visconti V; Brunetti G; Cuomo MR; Giordano A; Raponi G
    J Infect Chemother; 2017 Nov; 23(11):763-768. PubMed ID: 28899610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors, outcomes, and molecular epidemiology of Clostridioides difficile diarrhea in Brazilian hospitals.
    Girão ES; de Melo Tavares B; Dos Santos SA; Gamarra GL; Rizek C; Martins RC; Neto LVP; Diogo C; D' Annibale Orsi T; Morales HMP; da Silva Nogueira K; Maestri AC; Boszczowski I; Piastrelli F; Costa CL; Costa DV; Maciel G; Romão J; Guimarães T; de Castro Brito GA; Costa SF
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1821-1832. PubMed ID: 33783664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
    Duclaux-Loras R; Berthiller J; Ferroni A; Chardot C; Goulet O; Lacaille F; Norsa L
    Transplantation; 2020 Jan; 104(1):197-200. PubMed ID: 31205257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
    Djuikoue IC; Tambo E; Tazemda G; Njajou O; Makoudjou D; Sokeng V; Wandji M; Tomi C; Nanfack A; Dayomo A; Lacmago S; Tassadjo F; Sipowo RT; Kakam C; Djoko AB; Assob CN; Andremont A; Barbut F
    Infect Dis Poverty; 2020 Aug; 9(1):122. PubMed ID: 32867842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital.
    Shin BM; Moon SJ; Kim YS; Shin WC; Yoo HM
    J Clin Microbiol; 2011 Jun; 49(6):2161-5. PubMed ID: 21471341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
    Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
    J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.
    Stevens VW; Nelson RE; Schwab-Daugherty EM; Khader K; Jones MM; Brown KA; Greene T; Croft LD; Neuhauser M; Glassman P; Goetz MB; Samore MH; Rubin MA
    JAMA Intern Med; 2017 Apr; 177(4):546-553. PubMed ID: 28166328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
    Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
    J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.
    Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y
    BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients.
    Iwashima Y; Nakamura A; Kato H; Kato H; Wakimoto Y; Wakiyama N; Kaji C; Ueda R
    J Infect Chemother; 2010 Oct; 16(5):329-33. PubMed ID: 20449624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
    Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.
    Pilate T; Verhaegen J; Van Ranst M; Saegeman V
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1741-1747. PubMed ID: 27393490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
    Riley TV; Collins DA; Karunakaran R; Kahar MA; Adnan A; Hassan SA; Zainul NH; Rustam FRM; Wahab ZA; Ramli R; Lee YY; Hassan H
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.